Abstract

Recent advancements in drug delivery systems have revolutionized the field of medicine by enhancing the effectiveness and precision of therapeutic interventions. Nanotechnology has emerged as a key player in this paradigm shift, offering innovative strategies to improve drug delivery, bioavailability, and targeting. This review highlights the progress made in drug delivery systems, focusing on the integration of nanotechnology and targeted therapies. The utilization of nanoparticles, liposomes, micelles, and other nanoscale carriers has enabled controlled and sustained release of drugs, minimizing side effects and maximizing therapeutic outcomes. Moreover, the development of targeted therapies has further refined treatment approaches, allowing for personalized medicine and reduced off-target effects. Key challenges and future prospects in the field are also discussed, emphasizing the need for continued research and collaboration to unlock the full potential of these advancements and ultimately improve patient care.